Rare diseases
Investigational molecules
Locations
Back to Belgium899 clinical trials in Gent, Belgium across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Elenestinib for Patients with Indolent Systemic Mastocytosis
BelgiumStudy Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer
BelgiumStudy of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine
BelgiumStudy of Amoxicillin-clavulanic acid, Piperacillin-tazobactam and Meropenem dosing in critically ill children with systemic infections
BelgiumStudy on Adding Atezolizumab and WT1/DC Vaccine to Standard Treatment for Patients with Epithelioid Malignant Pleural Mesothelioma
BelgiumStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination
BelgiumStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
BelgiumStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
BelgiumStudy of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response
BelgiumStudy on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration
BelgiumStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
BelgiumStudy on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on vaccine development for various infectious diseases including influenza, RSV, and cytomegalovirus. Studies evaluating immune responses in both healthy volunteers and specific populations.
Research includes evaluation of vaccine safety, immunogenicity, and effectiveness across different age groups.
Innovative research targeting chronic respiratory conditions and nasal health, including studies on rhinitis medicamentosa and chronic rhinosinusitis.
Trials focus on both therapeutic interventions and long-term disease management strategies.
Studies examining new treatments for inflammatory diseases including psoriasis, psoriatic arthritis, and biliary conditions.
Research aims to improve treatment outcomes and quality of life for patients with chronic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
